ASR Vermogensbeheer’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
ASR Vermogensbeheer's RMD Position: Q3 2026 in Review
ASR Vermogensbeheer increased its ResMed (RMD) stake by 10% in Q3 2026, buying an estimated $247K and bringing the position to 12,421 shares worth $2.75M. The position accounts for 0.03% of the portfolio, ranked #355.
ASR Vermogensbeheer first reported a position in RMD in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.48M in Q3 2025. 878 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- ASR Vermogensbeheer held 12,421 shares of ResMed worth $2.75M as of Q3 2026.
- ASR Vermogensbeheer bought 1,131 ResMed shares in Q3 2026, an estimated $247K.
- ResMed made up 0.03% of ASR Vermogensbeheer's portfolio in Q3 2026, its #355 holding.
- ASR Vermogensbeheer first reported a position in ResMed in Q1 2025 and has held it in 7 quarters since.
- ASR Vermogensbeheer's ResMed position peaked at $3.48M in Q3 2025.
- 878 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on ASR Vermogensbeheer's 13F filing for Q3 2026, filed 16 Oct 2026.